Leo Jacobus Jozef Backx

This inventor holds 23 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Janssen Pharmaceutica Nv, Other. Active years: 2001-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leo Jacobus Jozef Backx. Retrieved from https://idiyas.com/inventor/leo-jacobus-jozef-backx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23

% Patents Active = 65.2

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3

Average Co-Inventor Count = 4.8

ph-index = 8

Forward Citations = 190(Granted Patents)

Location History:

Beerse B-2340, BE (2002)
Arendonck, BE (2010 - 2012)
Arendonk, BE (2001 - 2014)
Beerse, BE (2013 - 2014)

Company Filing History:

22 out of 2,101

Janssen Pharmaceutica Nv

patents

1 out of 834,513

Other

patents

Years Active: 2001-2014

Loading Chart...

Areas of Expertise:

Quinoline Derivatives

Antibacterial Agents

Histone Deacetylase Inhibitors

Polyarylcarboxamides

Lipid Lowering Agents

MTP Inhibitors

Piperidine Compounds

Sulfonylamino-derivatives

Apolipoprotein-B Inhibitors

Antifungal Ethers

Water Soluble Azoles

Triazolones

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8841321 - Quinoline derivatives as antibacterial agents (2014-09-23),

2. 8802671 - Quinoline derivatives as antibacterial agents (2014-08-12),

3. 8394831 - Carbonylamino-derivatives as novel inhibitors of histone deacetylase (2013-03-12),

4. 8354402 - Polyarylcarboxamides useful as lipid lowering agents (2013-01-15),

5. 8258304 - N-aryl piperidine substituted biphenylcarboxamides (2012-09-04),

6. 8163733 - Sulfonylamino-derivatives as novel inhibitors of histone deacetylase (2012-04-24),

7. 8158783 - MTP inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives (2012-04-17),

8. 8114880 - Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid MTP inhibiting compounds (2012-02-14),

9. 8071615 - Carbonylamino-derivatives as novel inhibitors of histone deacetylase (2011-12-06),

10. 7816360 - MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles (2010-10-19),

11. 7767679 - Sulfonylamino-derivatives as novel inhibitors of histone deacetylase (2010-08-03),

12. 7709487 - Sulfonyl-derivatives as novel inhibitors of histone deacetylase (2010-05-04),

13. 7528154 - Polyarylcarboxamides useful as lipid lowering agents (2009-05-05),

14. 7504400 - MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles (2009-03-17),

15. 7446109 - Carbonylamino-derivatives as novel inhibitors of histone deacetylase (2008-11-04),

Title: Leo Jacobus Jozef Backx: Pioneering Innovations in Antibacterial Agents

Introduction: Leo Jacobus Jozef Backx, a distinguished inventor from Arendonk, BE, has made significant contributions to the field of pharmaceuticals with 23 patents under his name. His latest patents focus on quinoline derivatives as antibacterial agents, showcasing his commitment to advancing healthcare solutions globally.

Latest Patents: Backx's recent patents involve the use of specific compounds for manufacturing medicaments to treat bacterial infections, excluding Mycobacterial infections. The compounds, characterized by complex formulae, demonstrate his expertise in developing innovative pharmaceutical solutions.

Career Highlights: With a prolific career, Backx has been associated with renowned companies such as Janssen Pharmaceutica NV, where he has made groundbreaking advancements in the pharmaceutical industry. His relentless pursuit of excellence and dedication to research have led to pioneering developments in antibacterial agents.

Collaborations: Throughout his career, Backx has collaborated with esteemed peers in the field, including Lieven Meerpoel and Marcel Viellevoye. Together, they have combined their expertise to drive innovation and address critical healthcare challenges.

Conclusion: Leo Jacobus Jozef Backx stands as a visionary inventor whose work in developing antibacterial agents has left a lasting impact on the pharmaceutical industry. His dedication to pushing the boundaries of innovation continues to inspire inventors and entrepreneurs worldwide, shaping the future of healthcare solutions.

Profile summary based on public USPTO records.